Cardinal Capital Management buys $846,192 stake in Masimo Corporation (MASI)

Masimo Corporation (MASI) : Cardinal Capital Management scooped up 1,244 additional shares in Masimo Corporation during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Apr 21, 2016. The investment management firm now holds a total of 19,529 shares of Masimo Corporation which is valued at $846,192.Masimo Corporation makes up approximately 0.35% of Cardinal Capital Management’s portfolio.

Masimo Corporation opened for trading at $43.55 and hit $44.73 on the upside on Wednesday, eventually ending the session at $44.64, with a gain of 2.81% or 1.22 points. The heightened volatility saw the trading volume jump to 4,12,777 shares. Company has a market cap of $2,209 M.

Other Hedge Funds, Including , Strs Ohio sold out all of its stake in MASI during the most recent quarter. The investment firm sold 27,600 shares of MASI which is valued $1,195,908.Gemmer Asset Management boosted its stake in MASI in the latest quarter, The investment management firm added 15 additional shares and now holds a total of 173 shares of Masimo Corporation which is valued at $7,425.Acadian Asset Management reduced its stake in MASI by selling 16,544 shares or 98.39% in the most recent quarter. The Hedge Fund company now holds 270 shares of MASI which is valued at $11,588.Capstone Asset Management Co reduced its stake in MASI by selling 770 shares or 4.54% in the most recent quarter. The Hedge Fund company now holds 16,176 shares of MASI which is valued at $694,274. Masimo Corporation makes up approx 0.02% of Capstone Asset Management Co’s portfolio.

On the company’s financial health, Masimo Corporation reported $0.15 EPS for the quarter, missing the analyst consensus estimate by $ -0.24 based on the information available during the earnings call on Feb 23, 2016. Analyst had a consensus of $0.39. The company had revenue of $167.30 million for the quarter, compared to analysts expectations of $164.26 million. The company’s revenue was up 3.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.40 EPS.

Masimo Corporation is a global medical technology company that develops manufactures and markets non-invasive patient monitoring products. The Company’s core business is measure-through-motion and low-perfusion pulse oximetry monitoring known as Masimo Signal Extraction Technology (SET) pulse oximetry. Its product offerings include non-invasive optical blood constituent monitoring optical organ oximetry monitoring electrical brain function monitoring acoustic respiration monitoring and optical gas monitoring. In addition the Company offers Root patient monitoring and connectivity platform the Radical-7 bedside and portable patient monitor and the Radius-7 wearable wireless patient monitor. The Company also has the Patient SafetyNet remote patient surveillance monitoring system which allows up to 80 patients to be monitored simultaneously through a central station or remotely by care providers through their pagers or smart phones.

Leave a Reply

Masimo Corporation - Is it time to Sell?

Top Brokerage Firms are advising their investors on Masimo Corporation. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.